Related references
Note: Only part of the references are listed.Novel Oligoamine Analogues Inhibit Lysine-Specific Demethylase 1 and Induce Reexpression of Epigenetically Silenced Genes
Yi Huang et al.
CLINICAL CANCER RESEARCH (2009)
Novel Structural Insights into Class I and II Histone Deacetylases
Ralf Ficner
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Polyamine analogues targeting epigenetic gene regulation
Yi Huang et al.
Essays in Biochemistry (2009)
RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling
Genqing Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A Novel Mammalian Flavin-dependent Histone Demethylase
Aristotele Karytinos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints
David N. Ciccone et al.
NATURE (2009)
Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast Cancer
Petr Novak et al.
CANCER RESEARCH (2008)
Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53
Tsing-Fen Ho et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Epigenetic regulation as a new target for breast cancer therapy
Vered Stearns et al.
CANCER INVESTIGATION (2007)
Carcinogen-induced histone alteration in normal human mammary epithelial cells
Chastity Bradley et al.
CARCINOGENESIS (2007)
Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression
Fei Lan et al.
NATURE (2007)
The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners
Ariane Scoumanne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes
Yi Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation
Qun Zhou et al.
CANCER BIOLOGY & THERAPY (2007)
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
Philip Kahl et al.
CANCER RESEARCH (2006)
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: Tamoxifen-bound reactivated ER recruits distinctive corepressor complexes
D Sharma et al.
CANCER RESEARCH (2006)
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
SD Gore et al.
CANCER RESEARCH (2006)
Regulation of LSD1 histone demethylase activity by its associated factors
YJ Shi et al.
MOLECULAR CELL (2005)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
The Sir2 family of protein deacetylases
G Blander et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
A novel histone deacetylase inhibitor, Scriptaid, enhances expression of functional estrogen receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine
JC Keen et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
